STAT3 is over-activated within CD163pos bone marrow macrophages in both Multiple Myeloma and the benign pre-condition MGUS

STAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomes

(2019) Morten Nørgaard Andersen et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Circulating extracellular vesicle‐associated CD163 and CD206 in multiple myeloma

(2019) Sarah L. Kvorning et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

STAT3 in Tumor-Associated Myeloid Cells: Multitasking to Disrupt Immunity

(2018) Yu-Lin Su et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The bone-marrow niche in MDS and MGUS: implications for AML and MM

(2018) Irene M. Ghobrial et al.   Nature Reviews Clinical Oncology

Macrophages are exploited from an innate wound healing response to facilitate cancer metastasis

(2018) Tamara Muliaditan et al.   Nature Communications

Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation

(2017) Nathan De Beule et al.   JOURNAL OF PATHOLOGY

Prognostic value of diametrically polarized tumor-associated macrophages in multiple myeloma

(2017) Xinyi Chen et al.   Oncotarget

Pro-inflammatory State in Monoclonal Gammopathy of Undetermined Significance and in Multiple Myeloma Is Characterized by Low Sialylation of Pathogen-Specific and Other Monoclonal Immunoglobulins

(2017) Adrien Bosseboeuf et al.   Frontiers in Immunology

Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy

(2016) Yoshihiro Komohara et al.   ADVANCED DRUG DELIVERY REVIEWS

Evaluation of the potential therapeutic benefits of macrophage reprogramming in multiple myeloma

(2016) A. Gutierrez-Gonzalez et al.   BLOOD

MGUS to myeloma: a mysterious gammopathy of underexplored significance

(2016) M. V. Dhodapkar   BLOOD

Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies

(2016) Daniela F. Quail et al.   CLINICAL CANCER RESEARCH

Strategy of STAT3β cell-specific expression in macrophages exhibits antitumor effects on mouse breast cancer

(2015) W Dang et al.   GENE THERAPY

Tumor-associated macrophages and extracellular matrix metalloproteinase inducer in prognosis of multiple myeloma

(2015) S Panchabhai et al.   LEUKEMIA

The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): Implications in multiple myeloma

(2015) Morten N. Andersen et al.   LEUKEMIA RESEARCH

IL10-driven STAT3 signalling in senescent macrophages promotes pathological eye angiogenesis

(2015) Rei Nakamura et al.   Nature Communications

The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells

(2015) Jinheng Wang et al.   Oncotarget

Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma

(2015) J. L. Jensen et al.   Cancer Immunology Research

Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma

(2014) Morten N. Andersen et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Tumor-Associated Macrophages: From Mechanisms to Therapy

(2014) Roy Noy et al.   IMMUNITY

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

(2014) S Vincent Rajkumar et al.   LANCET ONCOLOGY

Serial exome analysis of disease progression in premalignant gammopathies

(2014) S Zhao et al.   LEUKEMIA

Tumor-associated macrophages as a prognostic parameter in multiple myeloma

(2013) Elif Suyanı et al.   ANNALS OF HEMATOLOGY

Clinical significance of macrophage heterogeneity in human malignant tumors

(2013) Yoshihiro Komohara et al.   CANCER SCIENCE

A soluble form of the macrophage-related mannose receptor (MR/CD206) is present in human serum and elevated in critical illness

(2013) Sidsel Rødgaard-Hansen et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Macrophage biology in development, homeostasis and disease

(2013) Thomas A. Wynn et al.   NATURE

Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells

(2012) Maciej Bogdan Maniecki et al.   INTERNATIONAL JOURNAL OF CANCER

Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163

(2012) Anders Etzerodt et al.   JOURNAL OF CONTROLLED RELEASE

Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells

(2012) D Kim et al.   LEUKEMIA

PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma

(2012) Y Zheng et al.   LEUKEMIA

Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature

(2012) Qiong-wen Zhang et al.   PLoS One

Targeting Stat3 in the Myeloid Compartment Drastically Improves the In vivo Antitumor Functions of Adoptively Transferred T Cells

(2010) A. Herrmann et al.   CANCER RESEARCH

Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma

(2010) Horlad Hasita et al.   CANCER SCIENCE

Macrophage Diversity Enhances Tumor Progression and Metastasis

(2010) Bin-Zhi Qian et al.   CELL

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

(2010) Subhra K Biswas et al.   NATURE IMMUNOLOGY

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

(2009) O. Landgren et al.   BLOOD

Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis

(2009) Y. Zheng et al.   BLOOD

“Re-educating” tumor-associated macrophages by targeting NF-κB

(2008) Thorsten Hagemann et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Bone marrow microenvironment and the identification of new targets for myeloma therapy

(2008) K Podar et al.   LEUKEMIA

Pathogenesis and progression of monoclonal gammopathy of undetermined significance

(2008) J Bladé et al.   LEUKEMIA